Post-Authorization Safety Study of GSK Biologicals' Pandemic Influenza Vaccine (H1N1) in the United Kingdom
Clinical trial NCT00996853 · COMPLETED
Trial details
- NCT number
- NCT00996853
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2009-10-31
- Primary completion
- 2010-10-20
- Enrollment
- 9206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.